The Market Reports

Synopsis
The global market for Fish Oil EPA and DHA was estimated to be worth US$ 1625 million in 2024 and is forecast to a readjusted size of US$ 2020 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Fish Oil EPA and DHA cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Fish oil is a kind of oil extracted from fatty fish. It is rich in eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and various n-3 polyunsaturated fatty acids (n-3PUFA), which are essential unsaturated fatty acids for the human body. EPA can clean up blood vessel waste, soften blood vessels and improve immunity, and is known as the "blood vessel scavenger"; DHA is often used for pregnant women and infants. By taking DHA, it can promote the normal growth and development of the brain, thus playing a so-called brain-boosting and intelligence-enhancing effect, commonly known as "brain gold".
Rising Burden of Chronic Diseases Fuels Preventive Nutrition: As cardiovascular diseases, diabetes, neurodegenerative disorders, and systemic inflammation become global public health challenges, demand for preventive and functional nutrition is rising. EPA is well-known for its anti-inflammatory and triglyceride-lowering effects, while DHA supports neural and retinal development. These health benefits position EPA and DHA as essential components of daily supplementation, increasingly recommended by healthcare professionals.
Growing Focus on Cognitive and Brain Health Accelerates DHA Demand: With aging populations and heightened awareness of childhood cognitive development, DHA is gaining traction as a key structural component of the brain and nervous system. DHA supplementation is now routine in prenatal supplements, infant formula, and cognitive support products for aging adults, making it a central growth driver in the omega-3 category.
Expanding Middle Class and Health-Conscious Consumers Boost Uptake: In emerging markets, especially in Asia-Pacific, the expanding middle class and rising health literacy are driving the shift from curative medicine to preventive self-care. Fish oil supplements are increasingly viewed as affordable and accessible wellness investments by families looking to maintain long-term health.
Pharmaceutical-Grade EPA Adoption Reinforces Clinical Value: Prescription EPA products like icosapent ethyl have demonstrated strong clinical benefits in reducing cardiovascular risk. As more regulatory bodies and health systems embrace these results, the pharmaceutical segment is emerging as a high-value growth pillar, pushing the omega-3 industry further into the healthcare domain.
Advancements in Purification Technology Improve Quality and Appeal: Historically, concerns over fishy taste, oxidation, and contamination hindered broader omega-3 adoption. Today, molecular distillation, supercritical CO₂ extraction, and re-esterification techniques have led to purer, better-tasting, and more bioavailable products, greatly enhancing consumer trust and satisfaction.
This report aims to provide a comprehensive presentation of the global market for Fish Oil EPA and DHA, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Fish Oil EPA and DHA by region & country, by Type, and by Application.
The Fish Oil EPA and DHA market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fish Oil EPA and DHA.
Market Segmentation
By Company
KD Pharma
Croda
BASF
Yuwang Pharma
GC Rieber VivoMega
Pelagia (EPAX)
Golden Omega
TASA
KinOmega Biopharm
Omega Protein
Huatai Phrama
AlaskOmega (Wiley Companies)
Jiangsu Auqi Marine Biotechnology
Sinomega Biotech Engineering
Xinzhou Marine Biological Products
Nu-Mega (Clover)
Skuny Bioscience
Renpu Pharmaceuticals
Polaris
Solutex
Segment by Type
Fish Oil EPA
Fish Oil DHA
Segment by Application
Dietary Supplements
Fortified Foods and Beverages
Infant Formula
Pharmaceuticals
Pet Foods
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Fish Oil EPA and DHA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Fish Oil EPA and DHA in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Fish Oil EPA and DHA in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index